Market closedNon-fractional
DaVita/DVA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About DaVita
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the us, and treats about 250,000 patients globally each year. Government payers dominate us dialysis reimbursement. DaVita receives about two thirds of us sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of the us patients treated, they represent nearly all of the profits generated by DaVita in the us dialysis business.
Ticker
DVA
Sector
Healthcare
Trading on
NYSE
Industry
Health Care Providers and Services
Headquarters
Denver, United States
Employees
70,000
Website
www.davita.com
DaVita Metrics
BasicAdvanced
$12B
Market cap
16.19
P/E ratio
$8.80
EPS
0.87
Beta
-
Dividend rate
Price and volume
Market cap
$12B
Beta
0.87
Financial strength
Current ratio
1.426
Quick ratio
1.296
Long term debt to equity
429.156
Total debt to equity
449.224
Interest coverage (TTM)
3.42%
Management effectiveness
Return on assets (TTM)
6.36%
Return on equity (TTM)
43.22%
Valuation
Price to earnings (TTM)
16.193
Price to revenue (TTM)
1.041
Price to book
13.45
Price to tangible book (TTM)
-1.91
Price to free cash flow (TTM)
13.952
Growth
Revenue change (TTM)
5.77%
Earnings per share change (TTM)
60.50%
3-year revenue growth (CAGR)
2.29%
3-year earnings per share growth (CAGR)
10.80%
What the Analysts think about DaVita
Analyst Ratings
Majority rating from 8 analysts.
DaVita Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$3.1B
-2.39%
Net income
$240M
59.10%
Profit margin
7.80%
63.18%
DaVita Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$1.91
$2.62
$1.62
$2.65
-
Expected
$1.69
$2.02
$1.59
$1.95
$2.48
Surprise
12.80%
29.92%
1.67%
35.74%
-
DaVita News
AllArticlesVideos
DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call
PRNewsWire·1 week ago
Renal Denervation Devices Market Expected to Reach USD 387 Million by 2032 with a Remarkable 37.2% CAGR, According to Straits Research
GlobeNewsWire·1 week ago
US FTC probing DaVita, Fresenius Medical, Politico reports
Reuters·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for DaVita stock?
DaVita (DVA) has a market cap of $12B as of July 26, 2024.
What is the P/E ratio for DaVita stock?
The price to earnings (P/E) ratio for DaVita (DVA) stock is 16.19 as of July 26, 2024.
Does DaVita stock pay dividends?
No, DaVita (DVA) stock does not pay dividends to its shareholders as of July 26, 2024.
When is the next DaVita dividend payment date?
DaVita (DVA) stock does not pay dividends to its shareholders.
What is the beta indicator for DaVita?
DaVita (DVA) has a beta rating of 0.87. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell DaVita stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.